Heightened international attention on product quality, coupled with increasingly sensitive analytical technology, is instigating a flurry of FDA regulatory actions, class actions and personal injury lawsuits concerning impurities in food, drugs and other consumer health products. These cases present novel regulatory and legal issues that have historically not been the focus of product liability litigation, including the involvement of an increasing number of purportedly independent third-parties who file Citizen Petitions with FDA to initiate regulatory action and encourage litigation. Additionally, although the medical risks of trace-level contamination are often extremely low or non-existent, plaintiffs encourage courts and juries to apply a zero-tolerance standard to the presence of contaminants in these products. Members of King & Spalding's regulatory and litigation teams will discuss best practices for mitigating risk and litigating in this emerging area of product liability litigation.
If you have questions concerning this roundtable webinar, email Chayako Williams at firstname.lastname@example.org.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, email@example.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.